Quantifying family dissemination and identifying barriers to communication of risk information in Australian BRCA families

https://phgkb.cdc.gov/GAPPKB/phgHome.do




Last Posted: May 11, 2017

---

• Quantifying family dissemination and identifying barriers to communication of risk information in Australian BRCA families  
  E Healey et al, Genetics in Medicine, May 11, 2017
• "I Don't Want to Be an Ostrich": Managing Mothers' Uncertainty during BRCA1/2 Genetic Counseling.  
  Fisher Carla L et al. Journal of genetic counseling 2017 Jun 26(3) 455-468
• A Dedicated Follow-Up Clinic for BRCA Mutation Carriers.  
  Yerushalmi Rinat et al. The Israel Medical Association journal : IMAJ 2016 Sep 18(9) 549-552
• Systemic Treatment Strategies for Patients with Hereditary Breast Cancer Syndromes.  
  Parkes Amanda et al. The oncologist 2017 May
• A Retrospective Exploration of the Impact of the 'Angelina Jolie Effect' on the Single State-Wide Familial Cancer Program in Perth, Western Australia. 
  Freedman Rebecca et al. Journal of genetic counseling 2017 Feb 26(1) 52-62
• Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation.  
  Buchanan Adam H et al. Journal of genetic counseling 2017 Feb 26(1) 79-92
• Georgia Primary Care Providers' Knowledge of Hereditary Breast and Ovarian Cancer Syndrome.  
  Nair Navya et al. Journal of cancer education : the official journal of the American Association for Cancer Education 2017 Mar 32(1) 119-124
• Psychosocial and Clinical Factors Associated with Family Communication of Cancer Genetic Test Results among Women Diagnosed with Breast Cancer at a Young Age.  
  Elrick Ashley et al. Journal of genetic counseling 2017 Feb 26(1) 173-181
• Dueling BRCA Databases: What About the Patient?  
  R Lewis, PLOS Blogs, April 20, 2017
• When to Tell Daughters About a Genetic Breast Cancer Risk  
  JW Harris, NY Times, April 20, 2017
• Dueling BRCA Databases: What About the Patient?  
  R Lewis, PLOS Blogs, April 20, 2017
• A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer.  
  Eccleston Anthony et al. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2017 Apr 20(4) 567-576
• Breast cancer screening of pregnant and breastfeeding women with BRCA mutations.  
  Carmichael Harris et al. Breast cancer research and treatment 2017 Apr 162(2) 225-230
• Oncotype Dx recurrence score among BRCA1/2 germline mutation carriers with hormone receptors positive breast cancer.  
  Halpern Naama et al. International journal of cancer 2017 May 140(9) 2145-2149
• "When information is not enough": A model for understanding BRCA-positive previvors' information needs regarding hereditary breast and ovarian cancer risk.  
  Dean Marleah et al. Patient education and counseling 2017 Mar
• Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation.  
  Müller Dirk et al. The European journal of health economics : HEPAC : health economics in prevention and care 2017 Apr

more